Ayala Pharmaceuticals Announces $25 Million Strategic Financing
- SBIJI Innovation
- Feb 21, 2021
- 1 min read
Funding Extends Cash Runway through Multiple Expected Value Drivers Into 2023
Funds Expected to Support the Recently Announced Accelerated Development of AL102 for the Treatment of Desmoid Tumors into Pivotal Phase 2/3 Study
コメント